Abstract:With the rapid development of multi-omics technologies and accumulation of large-scale bio-datasets, many studies have conducted a more comprehensive understanding of human diseases and drug sensitivity from multiple biomolecules, such as DNA, RNA, proteins and metabolites. Using single omics data is difficult to systematically and comprehensively analyze the complex disease pathology and drug pharmacology. The molecularly targeted therapy-based approaches face some challenges, such as insufficient target gene labeling ability, and no clear targets for non-specific chemotherapeutic drugs. Consequently, the integrated analysis of multi-omics data has become a new direction for scientists to explore the mechanism of disease and drug. However, the available drug sensitivity prediction models based on multi-omics data still have problems such as overfitting, lack of interpretability, difficulties in integrating heterogeneous data, and the prediction accuracy needs to be improved. In this paper, we proposed a novel drug sensitivity prediction (NDSP) model based on deep learning and similarity network fusion approaches, which extracts drug targets using an improved sparse principal component analysis (SPCA) method for each omics data, and construct sample similarity networks based on the sparse feature matrices. Furthermore, the fused similarity networks are put into a deep neural network for training, which greatly reduces the data dimensionality and weakens the risk of overfitting problem. We use three omics of data, RNA sequence, copy number aberration and methylation, and select 35 drugs from Genomics of Drug Sensitivity in Cancer (GDSC) for experiments, including Food and Drug Administration (FDA)-approved targeted drugs, FDA-unapproved targeted drugs and non-specific therapies. Compared with some current deep learning methods, our proposed method can extract highly interpretable biological features to achieve highly accurate sensitivity prediction of targeted and non-specific cancer drugs, which is beneficial for the development of precision oncology beyond targeted therapy.

Structured penalized regression for drug sensitivity prediction

Multivariate Bayesian structured variable selection for pharmacogenomic studies

Comparison of the LASSO and Integrative LASSO with Penalty Factors (IPF-LASSO) methods for multi-omics data: Variable selection with Type I error control

Pan-Cancer Drug Sensitivity Prediction from Gene Expression using Deep Learning

Tissue-specific identification of multi-omics features for pan-cancer drug response prediction

DIVERSE: Bayesian Data IntegratiVE learning for precise drug ResponSE prediction

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction

Dual-Layer Strengthened Collaborative Topic Regression Modeling for Predicting Drug Sensitivity

Composite local low-rank structure in learning drug sensitivity

SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA

Group-sparse Modeling Drug-kinase Networks for Predicting Combinatorial Drug Sensitivity in Cancer Cells

A novel heterogeneous network-based method for drug response prediction in cancer cell lines

Anti-cancer Drug Synergy Prediction in Understudied Tissues using Transfer Learning

Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches

A comprehensive benchmarking of machine learning algorithms and dimensionality reduction methods for drug sensitivity prediction

Model ensembling as a tool to form interpretable multi-omic predictors of cancer pharmacosensitivity

From cell lines to cancer patients: personalized drug synergy prediction

Investigation of model stacking for drug sensitivity prediction

[Prediction of cancer drug sensitivity based on genomic feature distribution alignment and drug structure information]

Integrative Analysis of Prognosis Data on Multiple Cancer Subtypes using Penalization

Improving Drug Sensitivity Prediction and Inference by Multitask Learning